Medical Conditions Codexery

Inflammation

Biological defence response of body tissues to harmful stimuli.

Inflammation

Inflammation is the body’s biological defense response to tissue damage. It is a general, non-specific reaction—part of the innate immune system—that involves immune cells, blood vessels, and signaling molecules. Its purpose is to remove the cause of cell injury, clear away damaged cells and tissues, and start the repair process.

The response can be triggered by many things: physical trauma, dead or stressed tissues, pathogens, irritants, toxins, overuse, autoimmune reactions, allergens, and foreign bodies like silica or asbestos. When inflammation is too weak, the harmful stimulus (such as bacteria) can progressively destroy tissue and threaten survival. When it is too strong or persistent—as in chronic inflammation—it contributes to diseases like hay fever, gum disease, atherosclerosis, and osteoarthritis.

Inflammation is classified as acute or chronic. Acute inflammation is the immediate, short-term response to injury. It appears within minutes or hours and stops once the harmful stimulus is removed. It involves a coordinated mobilization of immune, endocrine, and neurological mediators. Neutrophils and macrophages migrate to the site, guided by cytokines and chemokines. Typical causes include pathogens, allergens, toxins, burns, and frostbite. The process begins with resident immune cells—such as macrophages, dendritic cells, and mast cells—that have pattern recognition receptors (PRRs). These receptors bind to pathogen-associated molecular patterns (PAMPs) from microbes or damage-associated molecular patterns (DAMPs) from injured host cells. Once activated, these cells release inflammatory mediators that cause the classic signs.

The five cardinal signs of acute inflammation, traditionally named in Latin, are: dolor (pain), calor (heat), rubor (redness), tumor (swelling), and functio laesa (loss of function). The first four were described by Celsus; the fifth was added later by Galen, Thomas Sydenham, or Rudolf Virchow. Pain results from chemicals like bradykinin and histamine that stimulate nerve endings. Heat and redness come from increased blood flow at body-core temperature to the inflamed area. Swelling is due to fluid accumulation. Loss of function can stem from pain limiting movement, swelling preventing motion, a reduced sense of smell during a cold, or difficulty breathing with bronchitis.

Chronic inflammation is a prolonged state that involves a shift in the types of cells present—especially mononuclear cells—and features simultaneous tissue destruction and healing. Its symptoms often include body pain, joint and muscle aches, chronic fatigue, insomnia, depression, anxiety, mood disorders, gastrointestinal issues (constipation, diarrhea, acid reflux), weight changes, and frequent infections.

Inflammation is also classified as Type 1 or Type 2, depending on the cytokines and T helper cells (Th1 or Th2) involved.

field
Immunology, Pathology
known_for
Five cardinal signs of inflammation: heat, pain, redness, swelling, loss of function
classification
Acute and chronic; Type 1 and Type 2 based on cytokines and T helper cells

Lore & Background

Inflammation can be triggered by a broad range of stimuli, including physical trauma, pathogens, irritants, toxins, autoimmunity, allergens, and foreign bodies such as silica and asbestos. The five cardinal signs—heat, pain, redness, swelling, and loss of function—were described in Latin as calor, dolor, rubor, tumor, and functio laesa. The first four were described by Celsus (c. 30 BC–38 AD), while the fifth, loss of function, is believed to have been added later by Galen, Thomas Sydenham, or Rudolf Virchow.

Reader's Guide

Inflammation is classified as acute or chronic. Acute inflammation is a short-term process appearing within minutes or hours, involving increased movement of plasma and leukocytes (especially granulocytes) from blood into injured tissues. Chronic inflammation lasts months or years, with a shift toward mononuclear cells such as macrophages, lymphocytes, and plasma cells, and involves simultaneous destruction and healing. Too little inflammation can lead to progressive tissue destruction, while too much, in the form of chronic inflammation, is associated with diseases such as hay fever, periodontal disease, atherosclerosis, and osteoarthritis. The process is initiated by resident immune cells that recognize pathogen-associated or damage-associated molecular patterns via pattern recognition receptors, releasing mediators that cause vasodilation, increased permeability, and leukocyte migration. Acute inflammation ceases once the stimulus is removed; chronic inflammation is promoted by factors such as obesity, smoking, stress, and insufficient diet.

Did You Know?

What Blepharitis Is and How It's Classified

Blepharitis—derived from the Greek word for "eyelid" combined with the suffix meaning "inflammation of"—stands as one of the most frequently encountered ocular conditions in clinical practice. It presents as a persistent inflammatory response concentrated at the base of the eyelashes, manifesting through reddening, scaling, crusting, and swelling of the lid margins. Patients often describe a grainy or gritty feeling, burning, and itching, particularly when any foreign substance touches the eye. While the condition itself does not directly threaten sight, it carries the risk of permanently reshaping the eyelid margin over time. The root cause most often lies in bacterial colonization and the resulting inflammation of congested meibomian oil glands, though both infectious and noninfectious triggers—ranging from bacterial infections to allergic reactions—can precipitate episodes. Clinicians recognize several distinct subtypes: seborrheic, staphylococcal, mixed, posterior (or meibomitis), and parasitic forms. A survey of American ophthalmologists and optometrists revealed that between 37 and 47 percent of their patients displayed signs of the condition, which can strike individuals of every age and ethnic background. One single-center study of ninety chronic patients reported an average age of fifty.

The Patient's Daily Experience

For someone living with blepharitis, the morning hours tend to be the most punishing. Crusting accumulates along the lid margins and the medial canthus overnight, causing the eyelids to stick together and making the first blink feel like wading through grit. The inflammation drives a cascade of uncomfortable sensations: a persistent itch, a burning or foreign-body feeling, and a flaking of the eyelid skin as the tear film becomes suppressed by clogged meibomian glands. Excessive tearing and dilated blood vessels give the eyes a perpetually watery, red appearance, while frequent blinking becomes a reflexive attempt to restore a compromised tear layer. In more advanced cases, patients notice misdirected lashes growing abnormally, progressive eyelash loss, or even a painful lump at the lash base signaling a stye. Blurred vision and light sensitivity can creep in as the tear film deteriorates, and tears may appear frothy or bubbly. Because the symptoms wax and wane in cycles of exacerbation and remission, patients frequently misattribute their complaints to "recurrent conjunctivitis," delaying proper diagnosis. Under magnification, debris in the tear film becomes visible, and fluorescein drops can improve contrast to reveal the full extent of surface disruption.

What Drives the Inflammation

The precise mechanism by which bacteria trigger blepharitis symptoms remains incompletely understood, though researchers point to direct irritation from bacterial toxins and an amplified cell-mediated immune response directed at Staphylococcus aureus. In staphylococcal blepharitis specifically, the anterior portion of the eyelid becomes infected, and culture studies show that 46 to 51 percent of affected patients harbor S. aureus, compared with only 8 percent of healthy controls. The condition can begin in childhood and persist into adulthood, tending to recur and demanding ongoing medical attention. Geographic variation in S. aureus prevalence across the conjunctival sac and lid margin likely reflects differences in climate and environment. Seborrheic blepharitis, by contrast, produces less overt inflammation but generates more greasy, oily scaling. Parasitic blepharitis offers a different pathway: the mite Demodex folliculorum, when present in excessive numbers within the eyelid dermis, inhabits hair follicles and associated sebaceous and apocrine glands, surviving roughly fifteen days per life cycle. Direct contact transmits the parasite, and conditions such as hypervascular tissue, poor hygiene, and immune deficiency create favorable environments for multiplication. Mechanical cleaning and diligent hygiene remain the cornerstones of reducing parasite loads. A long list of other dermatologic and infectious conditions—including rosacea, herpes simplex, varicella-zoster, molluscum contagiosum, and various forms of dermatitis—can also give rise to blepharitis.

When Left Untreated: The Cascade of Complications

Although blepharitis rarely threatens vision on its own, the chronic and untreated form sets in motion a troubling cascade of structural and functional damage. The eyelid margin can scar, lids may develop ulcerated, non-healing patches that bleed, and the architecture of the lash line can become permanently altered. Patients may find themselves unable to tolerate contact lenses, suffer from persistent excess tearing, or develop a stye—a painful infection at the base of the lashes—or a chalazion, a swollen, red blockage in a small oil gland just behind the lash line. The inflammation can spread to produce chronic conjunctivitis, keratitis, or even a corneal ulcer. Blurred vision resulting from a degraded tear film is another common endpoint, sometimes correctable with a proper eyeglass prescription. Frothy, bubbly tears contribute to mild scarring along the lids over time. In chronic bacterial cases, ectropion—a turning-out of the eyelid—may develop. Posterior or rosacea-associated blepharitis brings its own signature: broad-spectrum lid inflammation, plugging of the meibomian orifices, and the production of abnormal, thickened secretions when pressure is applied over the glands. A ring-like collarette around the lash shaft, broken or lost eyelashes, and a persistent foreign-body sensation round out the clinical picture of a condition that quietly erodes ocular comfort and function over months and years.

Frequently Asked Questions

Who is Inflammation?

Inflammation is the body's first-line tissue defense mechanism, activated whenever harmful stimuli damage cells. It operates as a core pillar of innate immunity, mobilizing immune cells, blood vessels, and chemical messengers to the affected site.

What are Inflammation's signature abilities?

Its most recognizable traits are the five cardinal signs: localized heat, pain, redness, swelling, and loss of function. Beyond these visible markers, it works to neutralize the original injury, clear away dead or damaged tissue, and kick-start the healing process.

How does Inflammation's arc resolve?

In its acute form, the response typically runs its course and subsides once the threat is eliminated and repair begins. When the trigger persists or the system malfunctions, however, it can shift into a chronic state that continues to damage tissue over time.

Why is Inflammation so central to the story?

Without this response, the body would lack a coordinated way to wall off and eliminate pathogens or repair structural damage at the cellular level. It sits at the intersection of immunology and pathology, making it a foundational concept in both fields.

What are Inflammation's known variants?

It is broadly divided into acute and chronic categories based on duration and intensity. A further split distinguishes Type 1 from Type 2 inflammation, differentiated by the specific cytokines involved and which T helper cell subtype drives the response.

More in Medical Conditions 1-15

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →